Advertisement
Screener

Cardio Diagnostics Holdings, Inc. (CDIO) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Cardio Diagnostics Holdings, Inc. Increase (Decrease) in Accrued Liabilities

Cardio Diagnostics Holdings, Inc. (CDIO) reported Increase (Decrease) in Accrued Liabilities of $1.98 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-11-07

  • Cardio Diagnostics Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was -$3.02K.
  • Cardio Diagnostics Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was -$1.11K.
  • Cardio Diagnostics Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was $6.11K.
Period endIncrease (Decrease) in Accrued Liabilities 1 monthIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 4 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 month
2022-09-30-$3.02K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$4.13K
derived: sum of 2 quarters · filed 2022-11-07
$1.98K
10-Q · filed 2022-11-07
2022-06-30-$1.11K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$5.00K
10-Q · filed 2022-08-10
2022-03-31$6.11K
10-Q · filed 2022-05-12
2021-09-30$0.00
10-Q · filed 2022-11-07
2021-06-30$0.00
10-Q · filed 2022-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
VOLITIONRX LTD (VNRX)$0.003B-0.64
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92